Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-31

Clinical Trial Update: Lurasidone Vs Olanzapine on Neurotrophic Biomarkers and Cardiometabolic Parameters in Unmedicated Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing lurasidone versus olanzapine in unmedicated schizophrenia focusing on neurotrophic biomarkers and cardiometabolic parameters; s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • lurasidone (lurasidone)
  • olanzapine (olanzapine)

Snippet

Sponsor: All India Institute of Medical Sciences, Bhubaneswar | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED